Vogelzang was a co-founder of the Kidney Cancer Association (KCA) in 1990 and served on its Board of Directors from its founding until his recent retirement in March of this year. Vogelzang became the first editor of the Textbook of Genitourinary Oncology, the first major textbook to focus on the field of GU oncology from the combined perspectives of the molecular biologist, pathologist, oncologist, and urologist, remaining its lead editor until recently.ĭr. Vogelzang served as Professor of Medicine and Urologic Surgery at the University of Chicago, serving as Chair of Genitourinary Oncology as well as Director for the University of Chicago Cancer Research Center.ĭr. He was particularly proud of the accomplishments of young investigators and those whose careers and research successes he had helped nurture over the years in treating GU cancers.Įarly in his career, Dr. Vogelzang helped organize GU oncologists, working to ensure that the field would have the necessary multi-disciplinary emphasis. Vogelzang led multiple groundbreaking clinical trials aimed at identifying new therapies and treatment approaches for cancer patients, investigating new therapies for GU cancers such as metastatic kidney cancer, prostate cancer, and metastatic bladder cancer, as well as for mesothelioma.ĭr. Vogelzang was known for his pioneering work in the world of GU oncology, providing extraordinary leadership in the field as well as in the development of clinical trials and therapeutics.Ī dedicated researcher, Dr. Vogelzang, or knew him personally, understood that he was warm, caring, professional, and knowledgeable to a fault, and simply an amazing physician and researcher.ĭr. Radium 223 treatment professional#Vogelzang (or Nick, as many of his colleagues knew him) dedicated his professional life to researching and treating rare forms of cancer. The Prostate Cancer Foundation (PCF) is sad to share news of the recent passing of a giant in the field of genitourinary (GU) medical oncology, Dr. Nicholas Vogelzang, renowned medical oncologist and cancer researcher specializing in genitourinary cancers, dies at 72. Support PCF in Your Workplace or Community.Featured The 29th Annual Scientific Retreat.Coffey – Holden Prostate Cancer Academy.28th Annual Scientific Retreat Video Replays.Featured Get the latest updates in health & wellness research.Featured Sign up for NewsPulse today and get groundbreaking information.Featured The latest prostate cancer research info.Featured PCF’s blog covers a wide range of topics.When to Get Checked for Prostate Cancer.Maintaining Health During Androgen Deprivation Therapy.Things Every Man Should Know About Prostate Cancer.Additional Facts for African American Men and Their Families.The Science of Living Well, Beyond Cancer.Precision Therapies for Prostate Cancer.What to Ask When Your PSA Is Rising After Initial Treatment.Localized or Locally Advanced Prostate Cancer.The Prostate-Specific Antigen (PSA) Test.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |